NCT03163641

Brief Summary

This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 23, 2017

Completed
1.2 years until next milestone

Study Start

First participant enrolled

August 5, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2018

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2018

Completed
Last Updated

December 17, 2020

Status Verified

January 1, 2019

Enrollment Period

3 months

First QC Date

May 17, 2017

Last Update Submit

December 14, 2020

Conditions

Keywords

Photorefractive Keratectomy, Corneal Defect

Outcome Measures

Primary Outcomes (1)

  • Time to corneal re-epithelization post PRK

    Time to corneal re-epithelization post PRK

    Day 3

Study Arms (3)

Treatment 1

EXPERIMENTAL

Ocular Bandage Gel

Device: Ocular Bandage Gel

Treatment 2

EXPERIMENTAL

Ocular Bandage Gel

Device: Ocular Bandage Gel

Control Group

ACTIVE COMPARATOR

Artificial tears with Acuvue Oasys

Device: Acuvue OasysDevice: Ocular Bandage Gel

Interventions

Bandage Contact Lens

Control Group

0.75% crosslinked HA

Control GroupTreatment 1Treatment 2

Eligibility Criteria

Age22 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Able and willing to comply with the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Houston, Texas

Houston, Texas, 77077, United States

Location

Related Publications (1)

  • Durrie DS, Wolsey D, Thompson V, Assang C, Mann B, Wirostko B. Ability of a new crosslinked polymer ocular bandage gel to accelerate reepithelialization after photorefractive keratectomy. J Cataract Refract Surg. 2018 Mar;44(3):369-375. doi: 10.1016/j.jcrs.2018.01.018.

Study Officials

  • Barbara Wirostko, M.D.

    Eyegate Pharmaceuticals, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Used a masked reading center to review the corneal defect staining.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2017

First Posted

May 23, 2017

Study Start

August 5, 2018

Primary Completion

October 31, 2018

Study Completion

November 8, 2018

Last Updated

December 17, 2020

Record last verified: 2019-01

Locations